Academics

HOME > Academics > Faculty of Medicine > Departments > Obstetrics & Gynecology > Perinatal medicine / Gynecology / Infertile Endocrine

Perinatal medicine / Gynecology / Infertile Endocrine

In our department, we are pursuing research, clinical practice and education in the fields of perinatal period, oncology and infertile endocrine.

Perinatal medicine

We aim for comprehensive perinatal management for mothers and children. The fetal management is based on detailed and real-time fetal information through continuous fetal growth assessment, biophysical profile score, and observation of fetal circulation dynamics using the ultrasonic pulse Doppler method. In particular, we are striving to detect abnormalities at an early stage using the fetal movement table for the purpose of monitoring the fetus between screening canyons.

On the other hand, in pregnancy management, early diagnosis using granular elastase as an index and preventive treatment with urinastatin suppository (developed in our department) are performed from the viewpoint of prevention of preterm birth, and pregnancy of gestational vesicle formation cases can be continued It has become. In addition, anticoagulant therapy (ATⅢ) and epidural anesthesia for gestational hypertension syndrome, MRA diagnosis for eclampsia and HELLP syndrome (involvement of vasospasm in this condition was first reported by our department) and antivasospasm In combination (experimental), we have developed a serodiagnosis method for amniotic fluid embolism, which is a major cause of maternal death, and responds to antibody measurement requests from Japan and overseas. Other perinatal periods such as advanced advanced medical management (eg blood purification and heparin therapy for antiphospholipid antibody syndrome), fetal therapy (fetal edema, etc.), cytomegalovirus, etc. We conduct screening for infectious diseases and vitamin K trans-milk feeding for infant vitamin K deficiency intracranial blood discharge.

Gynecology

We are aiming to improve cancer treatment results through multidisciplinary treatment such as surgery, chemotherapy, and radiation therapy. At present, the 5-year survival rate and other results are not particularly different from those of the statistics report for maternity women.

Cervical cancer: In addition to conventional surgery and radiation therapy, in-epithelial cancer is addressed by laser conical resection or photodynamic therapy (PDT).

Endometrial cancer: Preoperative evaluation by hysteroscope and MRI is performed. Depending on the stage of surgery, laparoscopic or laparoscopic surgery is performed, and postoperative therapy (hormone therapy, anticancer drug therapy or radiation therapy) is selected according to the degree of tissue differentiation and the degree of completion of the surgery.

Ovarian cancer surgery: Based on pelvic lymphadenectomy and omentectomy, postoperative chemotherapy is selected according to the degree of completion and the stage of surgery.

Villous disease: A multidisciplinary treatment combining anti-cancer drug therapy and surgical treatment.

End-of-life treatment for cancer patients

In-home treatment with reservoir (high calorie infusion), active management of cancer pain.

Infertile Endocrine

In vitro fertilization (IVF-ET) has been carried out since 1989, and microinsemination has been carried out since 1992. At present, the gametes are also cryopreserved as a medical indication for preserving fertility. In infertility treatment, we have a schedule for the prevention of such problems as multiple pregnancy and ovarian hyperstimulation syndrome.

In addition, we deal with various problems in an aging society, such as menopausal hormone replacement therapy, urinary incontinence treatment (surgical treatment), osteoporosis treatment, and Kampo treatment.